See More Hear More Watch More Hear More Get on iTunes
re/code recode

Cheaper Breast & Ovarian Cancer Tests

Color Genomics said it had raised $15 million from two prominent venture firms and a spate of high-profile women angel investors, in an effort to make a breast and ovarian cancer genetic risk test that is affordable. #tech


More from